Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Market Cap

Enanta Pharmaceuticals has a market cap or net worth of $278.20 million as of April 23, 2024. Its market cap has decreased by -63.54% in one year.

• Market Cap: 278.20M
• Enterprise Value: -27.70M
• 1-Year Change: -63.54%
• Ranking: #3366
• Category: Micro-Cap
• Stock Price: $13.15

Market Cap Chart

Since March 21, 2013, Enanta Pharmaceuticals's market cap has decreased from $289.30M to $278.20M, a decrease of -3.84%. That is a compound annual growth rate of -0.35%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	284.30M	0.89%
Apr 19, 2024	281.80M	0.68%
Apr 18, 2024	279.90M	-5.50%
Apr 17, 2024	296.20M	-8.86%
Apr 16, 2024	325.00M	-4.89%
Apr 15, 2024	341.70M	-1.81%
Apr 12, 2024	348.00M	-1.81%
Apr 11, 2024	354.40M	1.29%
Apr 10, 2024	349.90M	-1.66%
Apr 9, 2024	355.80M	2.80%
Apr 8, 2024	346.10M	-0.92%
Apr 5, 2024	349.30M	2.04%
Apr 4, 2024	342.30M	-3.17%
Apr 3, 2024	353.50M	2.20%
Apr 2, 2024	345.90M	-3.94%
Apr 1, 2024	360.10M	-2.52%
Mar 28, 2024	369.40M	5.63%
Mar 27, 2024	349.70M	3.65%
Mar 26, 2024	337.40M	14.41%
Mar 25, 2024	294.90M	-4.47%
Mar 22, 2024	308.70M	-0.26%
Mar 21, 2024	309.50M	0.88%
Mar 20, 2024	306.80M	3.30%
Mar 19, 2024	297.00M	3.92%
Mar 18, 2024	285.80M	-4.92%

View and export this data all the way back to 2013. Sign Up Today.

Related Stocks

Company	Market Cap
AxoGen	292.94M
ESSA Pharma	290.20M
Sutro Biopharma	288.84M
Pulmonx	288.46M
Q32 Bio	286.31M
Monte Rosa Therapeutics	286.13M
Akebia Therapeutics	285.79M
Nanobiotix	285.43M